Results 211 to 220 of about 34,804 (275)
Some of the next articles are maybe not open access.

Related searches:

Furosemide: Sublingual Administration

Hospital Pharmacy, 2008
Off-Label Drug Uses — This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Wolters Kluwer Health. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to
Joyce Generali, Dennis J. Cada
openaire   +1 more source

Dextromoramide pharmacokinetics following sublingual administration

Palliative Medicine, 1996
The extent of absorption and other pharmacokinetic parameters of dextromoramide following sublingual administration were assessed in five patients receiving chronic opioid analgesia. The use of the standard 5 mg tablet formulation was associated with negligible absorption in two patients, a prolonged time to peak concentration in the other three and ...
Jones, Terry E.   +3 more
openaire   +2 more sources

Hypoxemia following the administration of sublingual nitroglycerin

The American Journal of Medicine, 1978
Nitroglycerin, 0.6 mg sublingually, was given to 27 nonasthmatic subjects with varying degrees of airways dysfunction to determine the effect on arterial oxygenation. In six normal subjects, the partial pressure of oxygen in arterial blood (Pao2) transiently decreased by 9 mm Hg (p less than 0.05) and in eight subjects with only small airways ...
C A, Hales, D, Westphal
openaire   +2 more sources

Myocardial Infarction following Administration of Sublingual Ergotamine

Chest, 1982
Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine.
L S, Klein   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy